Can disposable surgical tools make hip replacement cheaper and safer?
NCT ID NCT04903860
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial compares two types of surgical tools used during total hip replacement: single-use (disposable) reaming instruments and conventional reusable ones. The main focus is on the overall cost of surgery, including sterilization, materials, and operating room time. Researchers will also track surgical time and patient recovery scores. The study involves 40 adults undergoing their first hip replacement due to arthritis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- single-use ancillary reaming material
- What this could lead to
- If single-use tools prove cost-effective and safe, they could become a standard option for hip replacement surgery, potentially reducing infection risks and streamlining hospital logistics.
- What could go wrong
- The trial is small and early, so results may not apply broadly. Single-use tools might be more expensive or offer no clear benefit over reusable ones.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Jul 2021
- Finished
-
Jul 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * \- Patient, male or female, over 18 years of age, eligible for a first-line total hip replacement for isolated coxarthrosis * Patient registered to the national health system * Patient able to understand information about the protocol and answer to questionnaire Exclusion Criteria: * Pregnant, breastfeeding or potentially pregnant woman * Major disability * History of hip replacement surgery * Any surgical and/or anesthetic contraindication, or any condition deemed by the investigator to be incompatible with the research. * Morbid obesity as defined by body mass index (BMI) \>40 kg.m-2 * History of recent infection at the surgical site * Surgical contraindication * Refusal to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coxarthrosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU clermont-ferrand
Clermont-Ferrand, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI chat coach may spot complications after joint replacement surgery
- Can unstable surfaces rebuild balance after hip replacement?
- Muscle loss may slow hip replacement recovery — a trial tests whether exercise can help
- Can a nerve pain drug cut opioid use after hip surgery?
- Hip replacement study halted early: what it means for pelvic movement
- Hip replacement recovery: could your smartphone replace paper forms?